| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coherus Oncology, Inc. (CHRS) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. CHRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 30.0K | $44.4K | - | |
| CFO | 15.0K | $22.2K | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2015 | Lanfear Dennis M | President And CEO | Sell | 400 | $31.75 | $12,700.00 | - | |
| Nov 13, 2015 | Richards Christos | Director | Sell | 15,000 | $27.49 | $412,424.93 | -6.7% | |
| Nov 2, 2015 | Herman Alan C. | Chief Scientific Officer | Sale+OE | 18,416 | $28.71 | $528,688.90 | -4.1% | |
| Oct 1, 2015 | Herman Alan C. | Chief Scientific Officer | Sale+OE | 4,250 | $18.98 | $80,644.25 | -1.0% | |
| Sep 1, 2015 | Herman Alan C. | Chief Scientific Officer | Sale+OE | 11,333 | $27.39 | $310,393.06 | -2.5% | |
| Aug 18, 2015 | Wahlstrom Mats58 | Director | Sell | 6,373 | $33.50 | $213,508.25 | -1.1% | |
| Aug 17, 2015 | Wahlstrom Mats58 | Director | Sell | 8,028 | $33.91 | $272,224.66 | -1.4% | |
| Aug 14, 2015 | Wahlstrom Mats58 | Director | Sell | 116,554 | $34.24 | $3,990,377.71 | -16.4% | |
| Aug 3, 2015 | Herman Alan C. | Chief Scientific Officer | Sale+OE | 14,166 | $34.83 | $493,413.11 | -6.2% | |
| Jul 30, 2015 | Troendle August J.71 | Director | Sell | 340,000 | $33.84 | $11,504,563.68 | -4.0% |